Implementation costs of skin infection surveillance in the Kimberley: learnings from the SToP Trial

Background The SToP (See, Treat, Prevent) Trial implemented a skin-control program to reduce impetigo in remote Kimberley Aboriginal communities. We aimed to estimate the cost of conducting the school-based skin screening component of the SToP Trial and estimate the annual costs of two feasible service delivery approaches for ongoing screening in remote Aboriginal communities: an Outreach approach and a Community-Owned approach delivered by a local school-based health workforce. Methods A retrospective micro-costing of skin screening trips (2019; 2022) to nine communities was conducted from a healthcare provider perspective. Year-specific costs were inflation-adjusted to 2024 Australian Dollars (AUD) and reported per trip and per child. One-way sensitivity analyses and scenario-based cost estimates were used to compare Outreach and Community-Owned approaches. Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12618000520235. Results Mean cost per trip in 2024 AUD decreased 16.6%, from $159,928 (2019) to $133,354 (2022); cost per child for screening in 2019 and 2022 was $445 and $478, respectively as fewer children were screened in 2022 due to COVID-19 disruptions. In 2022, costs were dominated by fixed costs, primarily staff costs (60.5% of total). Annual estimated costs were $210,666 for Outreach, $183,287 for Community-Owned delivery led by an Aboriginal Health Worker and $260,223 for Community-Owned delivery led by a school health nurse. Conclusions School-based skin screening has predictable, staffing-dominated costs. Estimated costs varied by staffing configuration, with Community-Owned delivery led by an Aboriginal Health Worker having the lowest annual cost. Community-Owned delivery was preferred by consulted stakeholders, although this study did not assess cost-effectiveness or comparative clinical outcomes. These costings can guide implementation and scale-up of culturally responsive skin screening programs to reduce skin infection burden and their resulting complications in remote Aboriginal communities.

Authors

Institutions

Publication Details

Journal
Archives of Dermatological Research
Published
2026-11-21
DOI
https://doi.org/10.1007/s00403-026-05042-3
Primary Topic
Indigenous Health, Education, and Rights
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Implementation costs of skin infection surveillance in the Kimberley: learnings from the SToP Trial

Judith Masha Katzenellenbogen, Lorraine Anderson, Jeffrey W. Cannon, Kate Maddams et al.
Archives of Dermatological Research
Indigenous Health, Education, and Rights
article

Implementation costs of skin infection surveillance in the Kimberley: learnings from the SToP Trial

Judith Masha Katzenellenbogen, Lorraine Anderson, Jeffrey W. Cannon, Kate Maddams, Ingrid Stacey, Marianne J. Mullane, Asha C Bowen, Stephanie Enkel, Hannah M.M. Thomas, On behalf of The SToP (See, Treat, Prevent) Skin Sores and Scabies Trial, Jules Custodio
article en

Abstract

Background The SToP (See, Treat, Prevent) Trial implemented a skin-control program to reduce impetigo in remote Kimberley Aboriginal communities. We aimed to estimate the cost of conducting the school-based skin screening component of the SToP Trial and estimate the annual costs of two feasible service delivery approaches for ongoing screening in remote Aboriginal communities: an Outreach approach and a Community-Owned approach delivered by a local school-based health workforce. Methods A retrospective micro-costing of skin screening trips (2019; 2022) to nine communities was conducted from a healthcare provider perspective. Year-specific costs were inflation-adjusted to 2024 Australian Dollars (AUD) and reported per trip and per child. One-way sensitivity analyses and scenario-based cost estimates were used to compare Outreach and Community-Owned approaches. Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12618000520235. Results Mean cost per trip in 2024 AUD decreased 16.6%, from $159,928 (2019) to $133,354 (2022); cost per child for screening in 2019 and 2022 was $445 and $478, respectively as fewer children were screened in 2022 due to COVID-19 disruptions. In 2022, costs were dominated by fixed costs, primarily staff costs (60.5% of total). Annual estimated costs were $210,666 for Outreach, $183,287 for Community-Owned delivery led by an Aboriginal Health Worker and $260,223 for Community-Owned delivery led by a school health nurse. Conclusions School-based skin screening has predictable, staffing-dominated costs. Estimated costs varied by staffing configuration, with Community-Owned delivery led by an Aboriginal Health Worker having the lowest annual cost. Community-Owned delivery was preferred by consulted stakeholders, although this study did not assess cost-effectiveness or comparative clinical outcomes. These costings can guide implementation and scale-up of culturally responsive skin screening programs to reduce skin infection burden and their resulting complications in remote Aboriginal communities.

Archives of Dermatological ResearchVol. 318(1)
The Kids Research Institute Australia (AU), The University of Western Australia (AU), Victor Chang Cardiac Research Institute (AU), Princess Margaret Hospital for Children (AU), WA Country Health Service (AU), Environs Kimberley (AU), Kimberley Aboriginal Medical Services (AU), Perth Children's Hospital (AU)
Indigenous Health, Education, and Rights
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon